Key result
Central contrast injection nearly doubles peak arterial enhancement vs peripheral delivery for IV-DSA.
Why the study?
Controversy exists regarding the selection of a central versus peripheral injection site for intravenous digital subtraction angiography (IV-DSA).
Does central injection improve the peak and width of the arterial time-concentration curve compared to peripheral injection for IV-DSA in dogs?
Does central injection improve the peak and width of the arterial time-concentration curve compared to peripheral injection for IV-DSA in dogs?
Central injection sites optimize IV-DSA examinations by providing greater peak enhancement and narrower time-concentration curves compared to peripheral injection.
Answers are grounded in this paper and cite their sources.
Central access may optimize IV-DSA contrast curves in dogs; leaves open translation to human angiography.
At a given radiation dosage and field of view, five variables are under meaningful control for intravenous digital subtraction angiography (IV-DSA): concentration and quantity of contrast media injected, volume of injectate, rate of injection, and site of injection. Some controversy exists regarding the selection of a central vs. a peripheral injection site for IV-DSA. This study determined the influence of the site of injection on the peak and width of the arterial time-concentration curve produced by contrast media. Using a noninvasive, in vivo, quantitative x-ray measurement method, 36 separate injections (10 ml of ioxaglate at 8 ml/sec) were administered into the cephalic vein, subclavian vein, and main pulmonary artery in dogs. Injection sites were varied using a Latin-square experimental design. Cardiac output, central blood volume and the peak and width of the contrast media time-concentration curves were measured. The average peak enhancement was greatest for the pulmonary artery injection site. Normalizing peak and width values to make the pulmonary artery values 100%, the average peak values for injections into the subclavian vein and cephalic vein were 93% and 56%, and the average widths were 141% and 163%, respectively. These data support the use of a more central injection site for optimizing IV-DSA examinations.
No takes yet. Share an insight, caveat, or question.
Rubin et al. (1984) studied Intravenous digital subtraction angiography (IV-DSA). Central injection (pulmonary artery or subclavian vein) vs. Peripheral injection (cephalic vein) was evaluated on Peak and width of the arterial time-concentration curve. Central injection into the pulmonary artery or subclavian vein produced higher peak enhancement and narrower curve widths than peripheral cephalic vein injection in dogs.
Synapse has enriched 10 related papers. Consider them for comparative context: